Colour enhancement - PsychonautWiki
Open main menu

Colour enhancement is defined as an intensification of the brightness and vividness of colors in the external environment. During this experience, reds may seem “redder”, greens may seem “greener", and all colors will likely appear much more distinct, complex, and visually intense than they comparatively would be during everyday sober living.[1][2][3][4][5][6][7][8] At higher levels, this effect can sometimes result in seeing colours which are perceived as surreal or seemingly impossible.[3][4]

Colour enhancement is often accompanied by other coinciding effects such as acuity enhancement and pattern recognition enhancement.[1][2] It is most commonly induced under the influence of mild dosages of psychedelic compounds, such as LSD, psilocybin, and mescaline. However, it can also occur to a lesser extent under the influence of certain stimulants and dissociatives such as MDMA, ketamine[9], or 3-MeO-PCP.

Image examples

 Caption
MDAI
Experience:25mg 3-MeO-PCP - Enhanced film experience
LSA
4-AcO-DMT
5-Hydroxytryptophan
3C-E
2C-B
Ayahuasca
25B-NBOMe
2C-T-21
Experience:1mg 25c-NBOMe - Experiment in my room
1P-LSD
DMT
Psilocin
2C-E
4-AcO-MET
DPT
2C-B-FLY
4-AcO-MiPT
DOC
MPT
Experience:2C-P (approx. 35mg) - Asymmetrical Terror and the Geometric Sea
Chur City in Switzerland.jpgChur, Switzerland by Naps284
4-HO-MiPT
1B-LSD
Experience:3g mimosa / 3g syrian rue - Connecting with my body
THJ-018
25C-NBOH
2C-I
Experience: 36mg 4-AcO-DiPT - Truly, one for the psychedelic animals among us
Efavirenz
Enhancementofcolour.jpgShowing differences by Chelsea Morgan
PRO-LAD
TMA-6
DOI
Experience:2.5g Syrian rue + 6g Mimosa Hostilis - Becoming God (my second experience with unity)
25D-NBOMe
Experience: 22mg 2C-B (oral) / 100ug 1P-LSD (sublingual) - My first time tripping alone (2 days in a row)
Experience:Unknown Dose DOC (Insufflated) - Overdosing and Terifying Ego Death
PARGY-LAD
3-MMC
MDA
4-AcO-DET
2C-D
1P-ETH-LAD
LSD
Bromo-DragonFLY
JWH-073
4-HO-MPT
Experience:Mushrooms and Snuff Films -- Trip Report (3.5 grams)
4-HO-DPT
Mescaline
Psilocybin mushrooms
Enhancement of colour rose.jpgRose by Chelsea Morgan
6-APDB
Experience:4-HO-MiPT / A care free psychedelic getaway
ETH-LAD
Experience: 15mg 2C-B (oral) - A pleasant low-dose evening with Nexus
LSZ
Escaline
Experience:3 Grams of Mushrooms - Reset on my Life, Experiencing Satori and the Cosmic Perspective
Paradise island by Xanny.jpgParadise island by Subsentience
5-MeO-MiPT
Proscaline
4-FA
Methallylescaline
Experience:337mg DMT fumarate - A Day With DMT
6-APB
Experience:40mg - Brothermind and the Forest's Hand
Experience:~150mg MDA(oral) - a case of mistaken identity
Selective serotonin reuptake inhibitor
Experience:225ug LSD + 9g cubensis - Galactic Melt and the Meverse
AL-LAD
4-HO-DET
25I-NBOH
Experience:BK-2C-B - Various experiences
MiPT
Pramiracetam
Experience:1000 Morning Glory seeds - Rediscovering the Self
5-MeO-DiPT
ΑMT
Phenylpiracetam
Experience:250mg DXM - DXM Itch and Trip Report
Experience: 5-EAPB (60mg) + 2-FMA (20mg) + 4-AcO-DMT (10mg) - Emotional catharsis
ALD-52
Experience:300µg AL-LAD - Don't worry, because you're everyone!
Experience:5.3g psilocybe cubensis - Dimensional Circumstance and the Fabric of Understanding
Coluracetam
Experience:4.5g - The Grand Introduction to Beauty and Fear
2C-C
Experience:4-AcO-DMT + 200mg Pill
25N-NBOMe
4-HO-EPT
Memantine
MDEA
Βk-2C-B
4-HO-MET
Piracetam
Experience:25mg Deschloroketamine - My first time orally dosing DCK
25C-NBOMe
2C-T-2
Experience:150mg MDMA + 20mg 2C-B - I designed it this way myself
2C-P
Enhancement of colours - woods.jpgThe Woods by Chelsea Morgan
LSM-775
2C-H
4-HO-DiPT
Phenethylamine (compound)
Experience:3-MeO-PCP - Extreme psychosis
Aniracetam
Experience:1050 µg 1cP-LSD - The matrix
Ibogaine
Experience:120mg - Garden of The Gods
Experience:Unknown dosage / 1 tab DOC - Psychedelia Turned Into Stimulant Psychosis
DOM
Experience:2 tabs DOB - My DOB Nightmare
Amanita muscaria
DET
5F-PB-22
Experience:800 seeds LSA - My First Trip Ever
Oxiracetam
MDMA
MET
DiPT
Experience:225mg Pregabalin +Cannabis -Bliss and Serenity; a hedonistic evening
Pregabalin
Chameleon.jpgChameleon by Anonymous.
Experience:3.5g psilocybe cubensis - Relinquishing of Material Chains/Fear and Desolation
25I-NBOMe
Experience:4x 200ug tabs - You do not need to understand
Tree.jpgJapanese Garden by Anonymous
THJ-2201
Experience:A combination of DOC, 5-MAPB, 5-MeO-DMT, ETH-LAD, Cannabis, Pentedrone
Allylescaline
Experience:75mg 3-FMA - Perfect Blend of Euphoria and Functionality
DOB
5-MeO-DiBF
GABAergic hallucinogens
JWH-018
5-MeO-DALT
Bufotenin
EPT
3-MeO-PCE
4-AcO-DiPT
Experience:300µg LSD - Togetherness and the Silent Dusk
Experience:300mg DXM + 25mg DMT + Cannabis - A crazy night
Experience:60mg 4-AcO-DMT Nonstop Quasi-Orgasmic Objectless Euphoria
25B-NBOH
Omberacetam
2C-T-7
MiPLA
TMA-2

Contents

Psychoactive substances

Experience reports

Annectdotal reports which describe this effect with our experience index include:

See also

External links

References

  1. 1.0 1.1 Papoutsis, Ioannis; Nikolaou, Panagiota; Stefanidou, Maria; Spiliopoulou, Chara; Athanaselis, Sotiris (2014). "25B-NBOMe and its precursor 2C-B: modern trends and hidden dangers". Forensic Toxicology. 33 (1): 1–11. doi:10.1007/s11419-014-0242-9. ISSN 1860-8965. 
  2. 2.0 2.1 Bersani, Francesco Saverio; Corazza, Ornella; Albano, Gabriella; Valeriani, Giuseppe; Santacroce, Rita; Bolzan Mariotti Posocco, Flaminia; Cinosi, Eduardo; Simonato, Pierluigi; Martinotti, Giovanni; Bersani, Giuseppe; Schifano, Fabrizio (2014). "25C-NBOMe: Preliminary Data on Pharmacology, Psychoactive Effects, and Toxicity of a New Potent and Dangerous Hallucinogenic Drug". BioMed Research International. 2014: 1–6. doi:10.1155/2014/734749. ISSN 2314-6133. 
  3. 3.0 3.1 Hartman, Alan M.; Hollister, Leo E. (1963). "Effect of mescaline, lysergic acid diethylamide and psilocybin on color perception". Psychopharmacologia. 4 (6): 441–451. doi:10.1007/BF00403349. ISSN 0033-3158. 
  4. 4.0 4.1 Kleinman, J. E.; Gillin, J. C.; Wyatt, R. J. (1977). "A Comparison of the Phenomenology of Hallucinogens and Schizophrenia From Some Autobiographical Accounts*". Schizophrenia Bulletin. 3 (4): 560–586. doi:10.1093/schbul/3.4.560. ISSN 0586-7614. 
  5. . doi:10.3389/Ffnhum.2015.00346.  Missing or empty |title= (help)
  6. Obreshkova, D., Kandilarov, I., Angelova, V. T., Iliev, Y., Atanasov, P., & Fotev, P. S. (2017). PHARMACO-TOXICOLOGICAL ASPECTS AND ANALYSIS OF PHENYLALKYLAMINE AND INDOLYLALKYLAMINE HALLUCINOGENS (REVIEW). PHARMACIA, 64(1), 41-42. http://bsphs.org/wp-content/uploads/2017/04/Angelova.pdf
  7. Abraham, Henry David (1983). "Visual Phenomenology of the LSD Flashback". Archives of General Psychiatry. 40 (8): 884. doi:10.1001/archpsyc.1983.01790070074009. ISSN 0003-990X. 
  8. Baggott, M.J.; Coyle, J.R.; Erowid, E.; Erowid, F.; Robertson, L.C. (2011). "Abnormal visual experiences in individuals with histories of hallucinogen use: A web-based questionnaire". Drug and Alcohol Dependence. 114 (1): 61–67. doi:10.1016/j.drugalcdep.2010.09.006. ISSN 0376-8716. 
  9. Dillon, P (2003). "Patterns of use and harms associated with non-medical ketamine use". Drug and Alcohol Dependence. 69 (1): 23–28. doi:10.1016/S0376-8716(02)00243-0. ISSN 0376-8716.